Taylor, Rod S. http://orcid.org/0000-0002-3043-6011
Bentley, Anthony
Metcalfe, Kaylie
Lobo, Melvin D.
Kirtane, Ajay J.
Azizi, Michel
Clark, Christopher
Murphy, Kieran
Boer, Jennifer H.
van Keep, Marjolijn
Ta, An Thu
Barman, Neil C.
Schwab, Garrett
Akehurst, Ron
Schmieder, Roland E.
Funding for this research was provided by:
ReCor Medical
Article History
Accepted: 7 January 2024
First Online: 30 January 2024
Change Date: 8 May 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s41669-024-00485-8
Declarations
:
: This work was supported by ReCor Medical.
: Rod S. Taylor has received personal consultancy fees from ReCor Medical. Anthony Bentley and Kaylie Metcalfe are employees of Mtech Access, contractor for ReCoR Medical. Melvin D. Lobo has received grant support from ReCor Medical and personal fees from ReCor Medical, Medtronic, CVRx, Ablative Solutions, Vascular Dynamics, ROX Medical and Tarilan Laser Technologies, as well as grants from Medtronic. Ajay J. Kirtane reports institutional funding to Columbia University and/or the Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, Siemens, Philips, ReCor Medical, and Neurotronic. In addition to research grants, institutional funding includes fees paid to Columbia University and/or the Cardiovascular Research Foundation for consulting and/or speaking engagements in which Ajay J. Kirtane controlled the content; personal: consulting from IMDS. Michel Azizi has received research grants from the French Ministry of Health, Quantum Genomics, and the European Horizon 2020 programme; has received grant support and nonfinancial support from ReCor Medical and Idorsia; and has received personal fees from CVRx. Christopher Clark has received personal fees from ReCor Medical and Bayer. Kieran Murphy is an employee of ReCor Medical. Jennifer H. Boer, Marjolijn van Keep and An Thu Ta were previously employed by BresMed, a contractor for ReCor Medical. Neil C. Barman is an employee of ReCor Medical. Garrett Schwab has received personal fees from ReCor Medical. Roland E. Schmieder has received research grants, paid to the institution, from ReCor Medical, Medtronic Inc. and Ablative Solutions, and has received personal consultancy and speaker fees from ReCor Medical, Medtronic Inc and Ablative Solutions.
: The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.
: Not applicable.
: Not applicable.
: Not applicable.
: The cost-effectiveness model was developed in Microsoft Excel 365 (Microsoft Corporation, Redmond, WA, USA). Any additional information about model programming is available from the corresponding author upon request.
: JNB, MvK, and RA constructed the first version of the economic model, which was updated by AB and KM. RST and KM wrote the first draft of this manuscript. All authors revised and contributed to subsequent versions of the manuscript, and the final version was approved by all authors.